跳至主要内容
临床试验/CTRI/2025/10/096476
CTRI/2025/10/096476
尚未招募
3 期

An Open-Label Exploratory Study on the Efficacy of a Multi-Ingredient Natural Topical Formulation STRETCH MARKS B GONE for the Management of Stretch Marks (Striae Distensae)

Dermesse Raw and Naturals Private Limited., India1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2025年11月6日最近更新:

概览

阶段
3 期
状态
尚未招募
发起方
Dermesse Raw and Naturals Private Limited., India
入组人数
25
试验地点
1
主要终点
Mean change from baseline, Week 2 and Week 4 in photo

概览

简要总结

This open-label exploratory study will evaluate the efficacy and safety of a natural topical formulation, STRETCH MARKS B GONE, for improving stretch marks (striae distensae).

Inclusion and Exclusion Criteria:

Twenty-five adults (20 females, 5 males) aged 18–45 years with visible stretch marks on the abdomen, hips, thighs, knees, or shoulders for at least 3 months to 1 year due to weight changes or postpartum effects will be enrolled. Participants will apply the product twice daily for 4 weeks.

The primary objective is to assess changes in stretch-mark appearance using photographic and morphometric analysis.

Secondary objectives include evaluation of skin hydration, elasticity, and patient-reported outcomes on dryness, itching, and comfort. Assessments will be performed at baseline, Week 2, and Week 4 to confirm visible improvement and product safety.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Adults 18–45 years.
  • Visible stretch marks (striae rubra or alba) on belly/hips/thighs/knees and shoulders, present Greater than or equal to 3 months to 1 years due to change in the body weight, Post Partum Changes.
  • Willing to refrain from other topical treatments/procedures on test areas during the study.
  • Able to comply and sign informed consent.

排除标准

  • Pregnant or breastfeeding.
  • Known allergy to any ingredient of test product.
  • Recent Greater than or equal to 3 topical retinoid, steroid, or procedural treatment on target areas.
  • Active dermatitis or infection in test area.
  • Participation in another clinical study within 30 days.

结局指标

主要结局

Mean change from baseline, Week 2 and Week 4 in photo

时间窗: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)

graded Visual Improvement Scale (VIS) and or percent change

时间窗: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)

in stretch-marks. (For those who give consent)

时间窗: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)

次要结局

  • 1. Skin texture: Mean percentage improvement - baseline and Week 4 (target: approx 25 percent improvement). Report mean ± SD and CI.((instrument plus Self-assessment))

研究者

发起方
Dermesse Raw and Naturals Private Limited., India
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Roshany

DK Elite Health Care Centre

研究点 (1)

Loading locations...

相似试验